These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

25 related articles for article (PubMed ID: 10822048)

  • 1. The Dual Endothelin-1 Antagonist Aprocitentan Alleviates Mitochondrial Oxidative Stress in Human Cardiac Fibroblasts.
    Varzideh F; Jankauskas SS; Jain U; Soderquist L; Agyapong ED; Kansakar U; Santulli G
    Eur Heart J Cardiovasc Pharmacother; 2024 Jul; ():. PubMed ID: 38977898
    [No Abstract]   [Full Text] [Related]  

  • 2. Salvianolic Acid A, as a Novel ETA Receptor Antagonist, Shows Inhibitory Effects on Tumor in Vitro.
    Zhang Q; Wang S; Yu Y; Sun S; Zhang Y; Zhang Y; Yang W; Li S; Qiao Y
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer genomics identifies regulatory gene networks associated with the transition from dysplasia to advanced lung adenocarcinomas induced by c-Raf-1.
    Rohrbeck A; Borlak J
    PLoS One; 2009 Oct; 4(10):e7315. PubMed ID: 19812696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I study of zibotentan (ZD4054) in patients with metastatic, castrate-resistant prostate cancer.
    Schelman WR; Liu G; Wilding G; Morris T; Phung D; Dreicer R
    Invest New Drugs; 2011 Feb; 29(1):118-25. PubMed ID: 19763400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZD4054: a specific endothelin A receptor antagonist with promising activity in metastatic castration-resistant prostate cancer.
    Warren R; Liu G
    Expert Opin Investig Drugs; 2008 Aug; 17(8):1237-45. PubMed ID: 18616419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin-1 as a target for therapeutic intervention in prostate cancer.
    Kopetz ES; Nelson JB; Carducci MA
    Invest New Drugs; 2002 May; 20(2):173-82. PubMed ID: 12099577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endothelin-1 in lung disease.
    Fagan KA; McMurtry IF; Rodman DM
    Respir Res; 2001; 2(2):90-101. PubMed ID: 11686871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin receptors: what's new and what do we need to know?
    Watts SW
    Am J Physiol Regul Integr Comp Physiol; 2010 Feb; 298(2):R254-60. PubMed ID: 19907001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced endothelin ET(B) receptor down-regulation in human tumor cells.
    Drimal J; Drimal J; Drimal D
    Eur J Pharmacol; 2000 May; 396(1):19-22. PubMed ID: 10822048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of [125I]-endothelin-1 and [125I]-BQ3020 binding to rat cerebellar endothelin receptors.
    Widdowson PS; Kirk CN
    Br J Pharmacol; 1996 Aug; 118(8):2126-30. PubMed ID: 8864551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin (ET)-1-induced inhibition of ATP release from PC-12 cells is mediated by the ETB receptor: differential response to ET-1 on ATP, neuropeptide Y, and dopamine levels.
    Gardner A; Westfall TC; Macarthur H
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1109-17. PubMed ID: 15687374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human peptide endothelin-1 and two of its sterically unrestrained C-terminal fragments on coronaryvascular smooth muscle.
    Drímal J; Drímal J; Orlický J; Janecek A; Kettmann V; Drímal D; Húzavová M
    Gen Physiol Biophys; 2002 Mar; 21(1):3-14. PubMed ID: 12168722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors.
    Nambi P; Pullen M; Spielman W
    J Pharmacol Exp Ther; 1994 Jan; 268(1):202-7. PubMed ID: 8301559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature.
    Davenport AP
    Pharmacol Rev; 2002 Jun; 54(2):219-26. PubMed ID: 12037137
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.